Krystal is leveraging a validated, redosable platform with high margins, profitability, and multiple blockbuster catalysts in CF and NK. Read why KRYS is a Buy.

Eyam Health Inc. today announced the publication of peer-reviewed research in Nature Communications describing Gemini™, a ...

Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...

The CCPA took suo-moto cognisance of the matter, discovering that toys were being sold on Snapdeal in violation of the Toys (Quality Control) Order, 2020, which became mandatory on 01st January, 2021.

Creative Biolabs, a leader in viral vector engineering and immunotherapy solutions, has announced the expansion of its ...

This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...

VANCOUVER, British Columbia, Feb. 17, 2026 (GLOBE NEWSWIRE) -- VR Resources Limited (“ VR ” or the “ Company ”, TSXV: VRR) is pleased to announce that the 3D-array DCIP geophysical survey is now ...

The new product offering will supply global life science researchers with performance and reliability in multi-fragment ...

Solid Biosciences (NASDAQ:SLDB) used a presentation at the 2026 Emerging Outlook Biotech Summit to outline its gene therapy-focused pipeline and discuss recent regulatory interactions around its lead ...

FDA RMAT boosts inhaled gene therapy KB707, delivering IL‑2/IL‑12 to lung tumors; early trial shows responses with manageable ...

D Molecular Therapeutics™, 4DMT™, Therapeutic Vector Evolution™, and the 4DMT logo are trademarks of 4DMT. All of the Company’s product candidates are in clinical or preclinical development and have ...

VectorY Therapeutics doses first participant in phase 1/2 PIONEER-ALS trial to evaluate VTx-002 in people with amyotrophic lateral sclerosis: Amsterdam Wednesday, February 11, 202 ...